Landec Corporation Sets Second Quarter Fiscal Year 2018 Conference Call for January 4, 2018 at 8 a.m. PT and Earnings Release set for January 3, 2018 After Market
SANTA CLARA, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Thursday January 4, 2018 at 8 a.m. Pacific time to discuss its results for the second quarter fiscal year 2018. Financial results will be reported for the 2018 fiscal second quarter ended November 26, 2017 after market close on January 3, 2018.
Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Thursday January 4, 2018
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (844) 860-6243
U.S. and International Toll Number: (661) 378-9884
Conference ID: 7084189
The webcast will be available for 30 days through February 3, 2018.
A replay of the teleconference will be available for one week until midnight Eastern time Thursday January 11, 2018.
Toll free replay dial in: (855) 859-2056
International replay: (404) 537-3406
Replay passcode: 7084189
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading innovator of diversified health and wellness solutions within the packaged natural food and biomaterial markets. Apio, Landec's food business, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Extending its reach into adjacent natural food products outside of produce, Landec recently acquired O Olive Oil, Inc., an organic and natural producer and marketer of olive oils and vinegars under the O brand. Lifecore Biomedical, Landec's biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec's website at www.landec.com.
CONTACT: Media and Industry Contact:
At the Company:
Gregory S. Skinner
Vice President Finance and CFO
John Mills, Partner